Study finds Hong Kong acquired hemophilia A patients are double that of Caucasian populations

A research team led by Dr. Albert Sin Chun-fung from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has achieved a significant breakthrough in characterizing territory-wide cohorts of acquired hemophilia A (AHA) patients in Hong Kong and identifying their prognostic factors. This discovery provides valuable insights for improving survival rates among patients with this rare but fatal blood disorder.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup